Akso Health (AHG) Common Equity (2017 - 2025)

Akso Health has reported Common Equity for 9 years, with the latest figure at $198.3 million in Q3 2025.

• For the quarter ending Q3 2025, Common Equity fell 1.13% year-over-year to $198.3 million; the trailing twelve-month figure through Sep 2025 stood at $198.3 million (down 1.13% YoY), and the FY2025 full-year result was $199.1 million, up 43.85% from the prior year.
• Common Equity for Q3 2025 stood at $198.3 million, roughly flat from $199.1 million in the prior quarter.
• The five-year high for Common Equity was $19552.2 billion in Q3 2021, with the low at $5.2 million in Q3 2023.
• Historically, Common Equity has averaged $1955.3 billion across 5 years, with a median of $77.8 million in 2021.
• Annual changes were most pronounced in 2021 — Common Equity soared 72276146.89% — and 2022, when it plunged 100.0%.
• Akso Health's Common Equity stood at $19552.2 billion in 2021, then sank by 100.0% to $9.9 million in 2022, then tumbled by 47.31% to $5.2 million in 2023, then soared by 3739.72% to $200.6 million in 2024, then declined by 1.13% to $198.3 million in 2025.
• The last three Common Equity figures came in at $198.3 million (Q3 2025), $199.1 million (Q1 2025), and $200.6 million (Q3 2024), per Business Quant data.